Murat Kalayoglu - 31 Mar 2026 SCHEDULE 13D/A Report for Cartesian Therapeutics, Inc. Common Stock (RNAC)

Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

20%

Beneficial ownership of this reported class.

Shares

5,833,971 shares

Shares beneficially owned as disclosed.

Event date

31 Mar 2026

Date tied to the ownership event or amendment.

Accepted by SEC

02 Apr 2026

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
RNAC
Shares outstanding
29,316,437 shares
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
02 Apr 2026, 17:37:40 UTC
Event date
31 Mar 2026
Source filing
View source filing

Key filing fact

Murat Kalayoglu disclosed 20% ownership in Cartesian Therapeutics, Inc. Common Stock (RNAC) on 31 Mar 2026.

Key facts

  • Murat Kalayoglu filed SCHEDULE 13D/A for Cartesian Therapeutics, Inc. Common Stock (RNAC).
  • Disclosed ownership: 20%.
  • Date of event: 31 Mar 2026.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 02 Apr 2026, 17:37.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (4)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Murat Kalayoglu 20% 5,833,971 5,833,971 0 /s/ Murat Kalayoglu Murat Kalayoglu 0002000002
Seven One Eight Three Four Irrevocable Trust 18% 5,313,261 5,313,261 0 /s/ Murat Kalayoglu Murat Kalayoglu, Authorized Person 0002000959
Elizabeth Hoge 18% 5,313,261 0 5,313,261 /s/ Murat Kalayoglu Murat Kalayoglu, Authorized Person 0002000987
Sinan Kalayoglu 18% 5,313,261 0 5,313,261 /s/ Murat Kalayoglu Murat Kalayoglu, Authorized Person
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .